Bayesian adaptive trials offer advantages in comparative effectiveness trials : an example in status epilepticus . 
<br>
<br> OBJECTIVE We present a novel Bayesian adaptive comparative effectiveness trial comparing three treatments for status epilepticus that uses adaptive randomization with potential early stopping . 
<br> STUDY DESIGN AND SETTING The trial will enroll 720 unique patients in emergency departments and uses a Bayesian adaptive design . 
<br> RESULTS The trial design is compared to a trial without adaptive randomization and produces an efficient trial in which a higher <font color="red">proportion_1</font> <font color="red">of_1</font> <font color="red">patients_1</font> <font color="red">are_1</font> <font color="red">likely_1</font> <font color="red">to_1</font> <font color="red">be_1</font> <font color="red">randomized_1</font> <font color="red">to_1</font> <font color="red">the_1</font> <font color="red">most_1</font> <font color="red">effective_1</font> <font color="red">treatment_1</font> <font color="red">arm_1</font> while generally using fewer <font color="red">total_1</font> <font color="red">patients_1</font> and offers higher <font color="red">power_1</font> than an analogous trial with fixed randomization when identifying a superior treatment . 
<br> CONCLUSION When one treatment is superior to the other two , the trial design provides better <font color="red">patient_1</font> <font color="red">care_1</font> <font color="red">,_1</font> higher <font color="red">power_1</font> <font color="red">,_1</font> and a lower <font color="red">expected_1</font> <font color="red">sample_1</font> <font color="red">size_1</font> <font color="red">._1</font>